Greenleaf Trust’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-12,885
| Closed | -$2.37M | – | 811 |
|
|
2025
Q4 | $2.37M | Buy |
12,885
+254
| +2% | +$44.5K | 0.02% | 173 |
|
|
2025
Q3 | $1.94M | Sell |
12,631
-149
| -1% | -$22.6K | 0.02% | 209 |
|
|
2025
Q2 | $1.79M | Sell |
12,780
-1,024
| -7% | -$144K | 0.02% | 217 |
|
|
2025
Q1 | $2.03M | Buy |
13,804
+252
| +2% | +$36.5K | 0.02% | 195 |
|
|
2024
Q4 | $1.78M | Buy |
13,552
+605
| +5% | +$84.7K | 0.02% | 214 |
|
|
2024
Q3 | $2.02M | Buy |
12,947
+25
| +0.2% | +$4.04K | 0.02% | 203 |
|
|
2024
Q2 | $2.02M | Buy |
12,922
+17
| +0.1% | +$2.56K | 0.02% | 180 |
|
|
2024
Q1 | $1.75M | Sell |
12,905
-943
| -7% | -$125K | 0.02% | 199 |
|
|
2023
Q4 | $1.87M | Sell |
13,848
-750
| -5% | -$97.5K | 0.02% | 185 |
|
|
2023
Q3 | $1.98M | Sell |
14,598
-2,803
| -16% | -$383K | 0.02% | 163 |
|
|
2023
Q2 | $2.49M | Buy |
17,401
+363
| +2% | +$53.4K | 0.03% | 139 |
|
|
2023
Q1 | $2.37M | Buy |
17,038
+1,387
| +9% | +$187K | 0.03% | 146 |
|
|
2022
Q4 | $2.12M | Sell |
15,651
-91
| -0.6% | -$11.4K | 0.03% | 153 |
|
|
2022
Q3 | $1.73M | Sell |
15,742
-257
| -2% | -$32.6K | 0.03% | 166 |
|
|
2022
Q2 | $2.11M | Buy |
15,999
+3,177
| +25% | +$417K | 0.03% | 129 |
|
|
2022
Q1 | $1.7M | Sell |
12,822
-846
| -6% | -$101K | 0.02% | 160 |
|
|
2021
Q4 | $1.59M | Buy |
13,668
+8
| +0.1% | +$941 | 0.02% | 167 |
|
|
2021
Q3 | $1.64M | Buy |
13,660
+646
| +5% | +$75.2K | 0.02% | 148 |
|
|
2021
Q2 | $1.56M | Sell |
13,014
-166
| -1% | -$18.2K | 0.02% | 162 |
|
|
2021
Q1 | $1.31M | Sell |
13,180
-610
| -4% | -$61.3K | 0.02% | 168 |
|
|
2020
Q4 | $1.38M | Sell |
13,790
-151
| -1% | -$16K | 0.02% | 140 |
|
|
2020
Q3 | $1.53M | Buy |
13,941
+387
| +3% | +$43K | 0.02% | 121 |
|
|
2020
Q2 | $1.43M | Buy |
13,554
+786
| +6% | +$81.2K | 0.03% | 121 |
|
|
2020
Q1 | $1.14M | Buy |
12,768
+1,367
| +12% | +$129K | 0.02% | 122 |
|
|
2019
Q4 | $1.14M | Sell |
11,401
-333
| -3% | -$31.4K | 0.02% | 153 |
|
|
2019
Q3 | $1.05M | Buy |
11,734
+682
| +6% | +$59.1K | 0.02% | 156 |
|
|
2019
Q2 | $912K | Buy |
11,052
+264
| +2% | +$20.7K | 0.01% | 176 |
|
|
2019
Q1 | $872K | Sell |
10,788
-2,995
| -22% | -$236K | 0.01% | 176 |
|
|
2018
Q4 | $1.05M | Buy |
13,783
+480
| +4% | +$37.5K | 0.02% | 148 |
|
|
2018
Q3 | $1.05M | Buy |
13,303
+743
| +6% | +$56.2K | 0.02% | 166 |
|
|
2018
Q2 | $882K | Buy |
12,560
+4,335
| +53% | +$312K | 0.02% | 178 |
|
|
2018
Q1 | $575K | Buy |
8,225
+643
| +8% | +$44.5K | 0.01% | 221 |
|
|
2017
Q4 | $526K | Buy |
7,582
+3,220
| +74% | +$217K | 0.01% | 239 |
|
|
2017
Q3 | $296K | Sell |
4,362
-1,538
| -26% | -$97.2K | 0.01% | 312 |
|
|
2017
Q2 | $402K | Buy |
+5,900
| New | +$385K | 0.01% | 232 |
|
Other funds holding AZN
IA
VCM
VAM
Greenleaf Trust's AZN Position: Q1 2026 in Review
Greenleaf Trust sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 12,885 shares — an estimated $2.37M sold.
Greenleaf Trust first reported a position in AZN in Q2 2017 and held it in 35 quarters. The position peaked at $2.49M in Q2 2023. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Greenleaf Trust reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
- Greenleaf Trust sold 12,885 AstraZeneca shares in Q1 2026, an estimated $2.37M.
- Greenleaf Trust first reported a position in AstraZeneca in Q2 2017 and held it in 35 quarters.
- Greenleaf Trust's AstraZeneca position peaked at $2.49M in Q2 2023.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Greenleaf Trust's 13F filing for Q1 2026, filed 27 Apr 2026.